@WHO: The meeting analyzed 15 vaccine trial designs from different developers, and criteria for conducting robust trials to assess safety and efficacy of #COVID19 vaccine candidates. 👉https://t.co/Unev4CEUIu https://t.co/z9lV1aMUKq

http://twitter.com/WHO
via IFTTT